112 related articles for article (PubMed ID: 8291447)
21. [Study on relationship between intratumoral DNA heterogeneity and clinicopathological findings in colorectal cancer].
Funahashi K; Tsujita K; Miki T; Koike J; Takatsuki M; Kubota S; Watanabe M; Yanagita K; Yoshio T
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():47-51. PubMed ID: 8203930
[TBL] [Abstract][Full Text] [Related]
22. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle parameters and DNA ploidy in colorectal carcinomas.
Yousuf N; Khan S; Sheikh Y; Hyams D; Bokhari J; Raza A
J Surg Res; 1991 Dec; 51(6):457-62. PubMed ID: 1943081
[TBL] [Abstract][Full Text] [Related]
24. [Malignancy in gastric cancer, with special reference to the distribution of BrdU-labelled cells].
Kamata T; Yonemura Y; Oyama S; Sugiyama K; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):335-9. PubMed ID: 2359389
[TBL] [Abstract][Full Text] [Related]
25. Nuclear DNA content, tumor cell aggregation, and metastatic events in patients with poorly differentiated adenocarcinoma of the stomach.
Watanabe A; Korenaga D; Maehara Y; Sugimachi K
Cancer; 1991 Aug; 68(4):815-20. PubMed ID: 1855182
[TBL] [Abstract][Full Text] [Related]
26. Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas. A new clinical application of DNA flow cytometric study?
Meling GI; Rognum TO; Clausen OP; Chen Y; Lunde OC; Schlichting E; Wiig JN; Hognestad J; Bakka A; Havig O
Cancer; 1991 Mar; 67(6):1642-9. PubMed ID: 2001553
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric DNA analysis in Japanese colorectal cancer. A multivariate analysis.
Tsuchiya A; Ando Y; Ishii Y; Yoshida T; Abe R
Eur J Surg Oncol; 1992 Dec; 18(6):585-90. PubMed ID: 1478291
[TBL] [Abstract][Full Text] [Related]
28. Ploidy in invasive colorectal cancer. Implications for metastatic disease.
Kim YJ; Ngoi SS; Godwin TA; DeCosse JJ; Staiano-Coico L
Cancer; 1991 Aug; 68(3):638-41. PubMed ID: 2065285
[TBL] [Abstract][Full Text] [Related]
29. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
Goodman A; Bell DA; Rice LW
Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
[TBL] [Abstract][Full Text] [Related]
30. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric analysis of the DNA content in primary and metastatic lesions of colorectal cancer.
Tomoda H; Inoue T
J Surg Oncol; 1995 Jun; 59(2):101-4. PubMed ID: 7776649
[TBL] [Abstract][Full Text] [Related]
32. [Flow cytometric DNA analysis of malignant potential in colorectal carcinoma--DNA ploidy pattern and liver metastasis].
Funai S; Kurooka K; Matsuda T; Ushida S; Sagara N; Shindo K; Yasutomi M
Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):127-32. PubMed ID: 2038287
[TBL] [Abstract][Full Text] [Related]
33. [Proliferative activity as a marker for lymph node metastases on early gastric cancers--in vitro bromodeoxyuridine labeling for clinical use].
Ohyama S; Yonemura Y; Kamata T; Kosaka T; Yamaguchi A; Kouichi ; Miwa ; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):354-9. PubMed ID: 2359392
[TBL] [Abstract][Full Text] [Related]
34. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
[TBL] [Abstract][Full Text] [Related]
35. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.
Lanza G; Maestri I; Dubini A; Gafa R; Santini A; Ferretti S; Cavazzini L
Am J Clin Pathol; 1996 May; 105(5):604-12. PubMed ID: 8623770
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
37. DNA ploidy in human colorectal adenocarcinomas.
Steinbeck RG; Heselmeyer KM; Neugebauer WF; Falkmer UG; Auer GU
Anal Quant Cytol Histol; 1993 Jun; 15(3):187-94. PubMed ID: 8347258
[TBL] [Abstract][Full Text] [Related]
38. ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.
Sun XF; Wingren S; Carstensen JM; Stål O; Hatschek T; Boeryd B; Nordenskjöld B; Zhang H
Eur J Cancer; 1991; 27(12):1646-9. PubMed ID: 1782077
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
Porschen R; Remy U; Bevers G; Schauseil S; Hengels KJ; Borchard F
Cancer; 1993 Jun; 71(12):3846-50. PubMed ID: 8508352
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
